Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma
Motoo Nomura, Isao Oze, Toshiki Masuishi, Tomoya Yokota, Hironaga Satake, Shunichiro Iwasawa, Ken Kato, Masashi Andoh
Topics & Concepts
MedicineNivolumabClinical endpointInternal medicineResponse Evaluation Criteria in Solid TumorsMelanomaAdverse effectPhases of clinical researchSurgical oncologyOncologyGastroenterologyMucositisProgression-free survivalSurgeryClinical trialCancerRadiation therapyChemotherapyImmunotherapyCancer researchCutaneous Melanoma Detection and ManagementOcular Oncology and TreatmentsCancer Immunotherapy and Biomarkers